JENNIFER SIZEMORE: Open Payments
NPI 1255965919 · MARIANNA, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$635 in 25 payments from 10 companies in 2025. Trend: 2023 $1,428 · 2024 $2,337 · 2025 $635
Food & beverage: $635
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 6 | $181 |
| Vanda Pharmaceuticals Inc. | 4 | $114 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $97 |
| Corium, LLC | 4 | $83 |
| ABBVIE INC. | 3 | $78 |
| Otsuka America Pharmaceutical, Inc. | 1 | $18 |
| Almatica Pharma LLC | 1 | $17 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
| Tris Pharma Inc | 1 | $15 |
| Janssen Pharmaceuticals, Inc | 1 | $15 |
Products named: LYBALVI, FANAPT, CAPLYTA, Azstarys, VRAYLAR, ARISTADA, REXULTI, LOREEV XR.
Industry payments across FL — which companies pay providers there.
